CA153 is an adjunct to the treatment and monitoring of breast cancer patients. Combined with other clinical and diagnostic measures, dynamic measurement is helpful for the early detection of recurrence after treatment of patients with stage II or stage III breast cancer; monitoring the treatment of patients with breast cancer metastasis Of reactivity. Therefore, CA153''s simple increase should be dynamically observed and combined with clinical. The increase alone cannot be used as a diagnostic indicator for cancer.

　　Carbohydrate antigen 15-3(CA15-3)

　　(1) Increased CA15-3 in breast cancer patients, early breast cancer sensitivity 60％, sensitivity of advanced breast cancer 80％.

　　 (2) Other malignant tumors also have a certain positive rate: such as: lung cancer, colon cancer, pancreatic cancer, ovarian cancer, cervical cancer, primary liver cancer, etc.

　　 (3) Liver, gastrointestinal tract, lung, breast, ovary and other non-malignant tumor diseases, the average positive rate